drugset / Trial / NCT00722735

Finafloxacin 300 mg Twice a Day (b.i.d.) Versus Ciprofloxacin 250 mg Twice a Day (b.i.d) in Patients With Lower Uncomplicated UTI (uUTI)

NCT00722735

Phase 2 Completed 36 enrolled MerLion Pharmaceuticals GmbH
RandomizedParallel-groupTriple-blindTreatment

Summary

To compare the bacteriological eradication rates of Finafloxacin and Ciprofloxacin in female patients with uUTI.

Timeline

Start
2008-10
Primary completion
2009-04
Completion
2009-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ciprofloxacin Small molecule 250 mg Oral
Subject Finafloxacin Small molecule 300 mg Oral